Table 2.
Compound No. | IC50 (µM)a | SIb | |
---|---|---|---|
COX-1 | COX-2 | ||
IIIa | 7.88 ± 0.14 | 4.78 ± 0.08 | 1.65 |
IIIb | 6.86 ± 0.12 | 2.51 ± 0.09 | 2.73 |
IIIc | 10.52 ± 0.24 | 3.87 ± 0.07 | 2.72 |
IIId | 4.00 ± 0.09 | 0.67 ± 0.02 | 5.97 |
IIIe | 7.52 ± 0.11 | 2.11 ± 0.07 | 3.56 |
IIIf | 11.23 ± 0.27 | 0.95 ± 0.01 | 11.82 |
IIIg | 9.20 ± 0.22 | 1.02 ± 0.03 | 9.02 |
IIIh | 7.84 ± 0.16 | 2.43 ± 0.07 | 3.23 |
IIIi | 3.25 ± 0.07 | 0.69 ± 0.02 | 4.71 |
Celecoxib | 7.34 ± 0.18 | 1.11 ± 0.04 | 6.61 |
Notes: aIC50: compound concentration required to produce 50% inhibition of COX-1 or COX-2 for means of three determinations, bold figures refer to submicromolar; bSI = IC50 (COX-1)/ IC50 (COX-2).